Preeti Futnani has been appointed as the Company’s General Manager For Vaccines, effective June 1, 2022, by Sanofi India. She was the Franchise Head for Dupixent Dermatology at Sanofi’s Greater Gulf MCO (a cluster of six countries that includes Saudi Arabia, the United Arab Emirates, and Kuwait).
Futnani has over two decades of experience in driving development and change in healthcare (primary and specialty care, medical technology) and finance.
She started her journey with Sanofi over six years ago in Specialty Care Gulf, after various roles of increasing responsibility in Novartis marketing and commercial operations across Switzerland, UK, and India. She has held leadership roles in marketing, sales, and management across several geographies from mature markets in the UK and EU to emerging markets in Asia and the Middle East.
Futnani succeeds Annapurna Das, who is elevated to Head of Vaccines, Asia. Futnani will be based in Mumbai, India.
Annapurna Das, Head of Asia Vaccines, said “We are delighted to have Preeti Futnani join us as the General Manager for Vaccines in India. Her global experience is an asset that will further sharpen Sanofi India’s focus of increasing vaccine coverage rates by drivingthe growth of our current portfolio and accelerating launch of innovative vaccines in the country. We wish her every success in this new role.”
Commenting on the new role, Futnani said “Vaccines isa priority growth driver for Sanofi. I am excited to join the team and lead the next phase of ambition for the business in India. Together, we are committed to safeguarding the Indian population from vaccine preventable diseases, at every stage of life, by leveraging the protective power of vaccination.”
